Skip to main content
D&D Pharmatech Inc. logo

D&D Pharmatech Inc. — Investor Relations & Filings

Ticker · 347850 ISIN · KR7347850000 KO Manufacturing
Filings indexed 119 across all filing types
Latest filing 2026-06-10 Investor Presentation
Country KR South Korea
Listing KO 347850

About D&D Pharmatech Inc.

http://www.ddpharmatech.com/

D&D Pharmatech is a clinical-stage biopharmaceutical company specializing in the development of therapies based on GLP-1 (Glucagon-like peptide-1) and related peptides. The company's pipeline primarily targets metabolic diseases, including obesity and MASH (Metabolic dysfunction-associated steatohepatitis), as well as neurodegenerative disorders. A core competency is its proprietary oral peptide delivery technology. Key candidates in its portfolio include DD01, an injectable dual GLP-1/glucagon receptor agonist for MASH that has received FDA Fast Track Designation, and an oral GLP-1 therapy for obesity. The company operates a global model, funding drug development through specialized subsidiaries, with research functions in Korea and clinical development managed by its US-based team.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Investor Presentation Classification · 85% confidence The document is an announcement for a corporate investor relations session (“기업설명회 (IR) 개최”) with details on date, time, location, participants, purpose, and how materials will be distributed. This is not a financial report or regulatory certification; it is clearly an Investor Presentation event notice. Thus it fits the “Investor Presentation (IP)” category.
2026-06-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서” submitted to the Securities and Futures Commission and Korea Exchange. It details the ownership status and changes in specific securities by an executive (director) of the company, including share counts before and after transactions. This matches the definition of an insider personal share transaction report by directors and executives. Therefore, it is classified as Director’s Dealing (DIRS).
2026-06-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is a mandatory disclosure by an executive and major shareholder detailing their ownership of specific securities, including past and current share counts and changes due to option exercises. This matches the definition of insider transactions or personal share dealings by company directors/executives. Therefore, it should be classified as a Director's Dealing report.
2026-06-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is a Korean regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서” which translates to an officer and major shareholder report on ownership of certain securities. It is a mandatory insider transaction disclosure (reporting changes in shareholdings by an executive) submitted to the securities regulator and stock exchange. This exactly matches the definition of Director’s Dealing (insider trades by directors/executives).
2026-06-09 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 89% confidence The document is a short regulatory announcement describing the logistics of an upcoming investor relations (IR) meeting (date, time, venue, purpose). It does not contain actual presentation materials, financial statements, transcripts, or voting results, nor is it announcing the publication of a report. Therefore it falls under the general Regulatory Filings category (RNS).
2026-06-05 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 90% confidence The document is an announcement of an upcoming investor relations event (기업설명회 IR), providing date, time, location, purpose, sponsor, and posting details on the KRX disclosure system. There are no financial statements, slides or detailed investor presentation materials—just a regulatory notice of an IR meeting. This fits the catch-all Regulatory Filings category (RNS).
2026-06-02 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.